dual 5-HT6/5-HT7 antagonists (Adamed)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual 5-HT6/5-HT7 antagonists (Adamed)
Drug Alias NameADN-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 7 (5-HT7) receptor antagonistsSerotonin 6 (5-HT6) receptor antagonistsDopamine D2 receptor antagonists
TargetsSerotonin 7 (5-HT7) receptorSerotonin 6 (5-HT6) receptorDopamine D2 receptor
Therapy Area/IndicationsDementia-related Psychosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdamed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdamed
Active IndicationsN/A
Inactive IndicationsDementia-related Psychosis

Other Information

ATC CodeN/A
Related LinksN/A